Across the past several years, health systems have invested in early-stage value-based care capabilities. Across the country, organizations have committed substantial time and resources to assemble and deploy value-based care assets, typically with the aim of gaining market share through risk contracts and improving outcomes through aligned incentives.

But many organizations have seen little material benefit to date. Market share gains have been underwhelming, and securing enough lives at risk to meaningfully change outcomes still seems like a distant goal for many.